Simplifying Global Compliance
Trial Investigator Warned Over Lack of SOP Documentation
Clinical Trials Advisor
A San Diego, Calif.-based clinical researcher received an FDA warning letter over its lack of documentation of standard operating procedures for overseeing studies and details of in-service protocol and specimen handling training in a Form 483 response.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing